Combinatorial QSAR Modeling of Specificity and Subtype Selectivity of Ligands Binding to Serotonin Receptors 5HT1E and 5HT1F-Reference-Cited by-同舟云学术

Combinatorial QSAR Modeling of Specificity and Subtype Selectivity of Ligands Binding to Serotonin Receptors 5HT1E and 5HT1F

Published:2008-05-01 Issue:5 Volume:48 Page:997-1013
ISSN:1549-9596
Container-title:Journal of Chemical Information and Modeling
language:en
Short-container-title:J. Chem. Inf. Model.

Author:

Wang Xiang S.¹,Tang Hao¹,Golbraikh Alexander¹,Tropsha Alexander¹

Affiliation:

1. Laboratory for Molecular Modeling, Division of Medicinal Chemistry and Natural Products and Carolina Exploratory Center for Cheminformatics Research, School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, and Molecular & Cellular Biophysics Program, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599

Publisher

American Chemical Society (ACS)

Subject

Library and Information Sciences,Computer Science Applications,General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ci700404c

Reference88 articles.

1. Modelling G-protein-coupled receptors for drug design

2. Telomerase therapeutics for cancer: challenges and new directions

3. The Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches?

4. Why Academic Drug Discovery Makes Sense

5. GLIDA: GPCR-ligand database for chemical genomic drug discovery

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico design and in vitro assessment of anti-Helicobacter pylori compounds as potential small-molecule arginase inhibitors;Molecular Diversity;2022-01-08

2. Synthesis, biological evaluation and molecular docking studies of novel 1,2,3-triazole-quinazolines as antiproliferative agents displaying ERK inhibitory activity;Bioorganic Chemistry;2021-08

3. Recent Advances in Development, Validation, and Exploitation of QSAR Models;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26

4. Structure–activity relationships and drug design;Remington;2021

5. QSAR Modeling of SARS‐CoV MproInhibitors Identifies Sufugolix, Cenicriviroc, Proglumetacin, and other Drugs as Candidates for Repurposing against SARS‐CoV‐2;Molecular Informatics;2020-08-24